JPMorgan Chase & Co’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
748,862
-2,014
| -0.3% | -$4.03K | ﹤0.01% | 3511 |
|
|
2025
Q1 | $1.88M | Sell |
750,876
-21,368
| -3% | -$53.4K | ﹤0.01% | 3305 |
|
|
2024
Q4 | $2.28M | Buy |
772,244
+772,228
| +4,826,425% | +$2.28M | ﹤0.01% | 3309 |
|
|
2024
Q3 | $48 | Hold |
16
| – | – | ﹤0.01% | 6057 |
|
|
2024
Q2 | $56 | Hold |
16
| – | – | ﹤0.01% | 5983 |
|
|
2024
Q1 | $84 | Hold |
16
| – | – | ﹤0.01% | 5925 |
|
|
2023
Q4 | $82 | Hold |
16
| – | – | ﹤0.01% | 6102 |
|
|
2023
Q3 | $84 | Sell |
16
-465
| -97% | -$2.44K | ﹤0.01% | 5970 |
|
|
2023
Q2 | $899 | Sell |
481
-4,819
| -91% | -$9.01K | ﹤0.01% | 5563 |
|
|
2023
Q1 | $20K | Buy |
5,300
+1,610
| +44% | +$6.08K | ﹤0.01% | 5143 |
|
|
2022
Q4 | $11K | Buy |
3,690
+63
| +2% | +$188 | ﹤0.01% | 5089 |
|
|
2022
Q3 | $17K | Buy |
3,627
+152
| +4% | +$712 | ﹤0.01% | 4969 |
|
|
2022
Q2 | $92K | Buy |
3,475
+437
| +14% | +$11.6K | ﹤0.01% | 4675 |
|
|
2022
Q1 | $113K | Buy |
3,038
+535
| +21% | +$19.9K | ﹤0.01% | 4690 |
|
|
2021
Q4 | $147K | Sell |
2,503
-4,008
| -62% | -$235K | ﹤0.01% | 4675 |
|
|
2021
Q3 | $536K | Sell |
6,511
-430
| -6% | -$35.4K | ﹤0.01% | 3919 |
|
|
2021
Q2 | $656K | Buy |
+6,941
| New | +$656K | ﹤0.01% | 3848 |
|